ArticleFrontiers in medicine2026

Circulating microRNAs as biomarkers of disease activity and treatment response in Crohn's disease patients receiving infliximab or vedolizumab: a longitudinal cohort study.

Luisa Bertin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.